Clinical significance of DJ-1 as a secretory molecule: Retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast

Histopathology

Volumn 61, Issue 1, 2012, Pages 69-77

  Tsuchiya, Benio ^a   Iwaya, Keiichi ^b,c   Kohno, Norio ^c   Kawate, Takahiko ^b,c   Akahoshi, Tohru ^a   Matsubara, Osamu ^b   Mukai, Kiyoshi ^d  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d SAISEIKAI CENTRAL HOSPITAL   (Japan)

Author keywords

DJ 1; Immunohistochemistry; In situ hybridization; Invasive ductal carcinoma; Prognosis; Tissue microarray

Indexed keywords

CYCLOPHOSPHAMIDE; DJ 1 PROTEIN; FLUOROURACIL; MESSENGER RNA; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; RNA, MESSENGER; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84862877806     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04202.x     Document Type: Article

References (27)

1. Nagakubo D, Taira T, Kitaura H et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun. 1997; 231; 509-513.
2. Clements C, McNally R, Conti B et al. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl Acad. Sci. USA 2006; 103; 15091-15096.
3. Fan J, Ren H, Jia N. DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J. Biol. Chem. 2008; 283; 4022-4030.
4. Kim RH, Peters M, Jang YJ et al. DJ-1, a novel regulator of the tumour suppressor PTEN. Cancer Cell 2005; 7; 263-273.
5. Le Naour F, Misek DE, Krause MC et al. Proteomic-based identification of RS/DJ-1 as a novel circulating tumour antigen in breast cancer. Clin. Cancer Res. 2001; 7; 3328-3335.
6. Pardo M, García Á, Thomas B et al. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int. J. Cancer 2006; 119; 1014-1022.
7. Tsuboi Y, Munemoto H, Ishikawa S et al. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains. FEBS Lett. 2008; 582; 2643-2649.
8. Maita C, Tsuji S, Yabe I et al. Secretion of DJ-1 into the serum of patients with Parkinson's disease. Neurosci. Lett. 2008; 431; 86-89.
9. Tian M, Cui YZ, Song GH et al. Proteomic analysis identifies MMP-9, DJ-1 and AIBG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 2008; 8; 241-252.
10. He XY, Liu BY, Yao WY et al. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer. J. Dig. Dis. 2011; 12; 131-137.
11. Davidson B, Hadar R, Schlossberg A et al. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum. Pathol. 2008; 39; 87-95.
12. Hod Y. Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J. Cell. Biochem. 2004; 92; 1221-1233.
13. Zhang HY, Wang HQ, Liu HM et al. Regulation of tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells. Endocr. Relat. Cancer 2008; 15; 535-544.
14. Liu S, Yang Z, Wei H et al. Increased DJ-1 and its prognostic significance in hepatocellular carcinoma. Hepatogastroenterology 2010; 57; 1247-1256.
15. Zhang HJ, Siu MK, Jiang LL et al. Overexpression of the Parkinson disease protein DJ-1 and its regulator PTEN in gestational trophoblastic disease. Int. J. Gynecol. Pathol. 2010; 29; 468-475.
16. Liu H, Wang M, Li M et al. Expression and role of DJ-1 in leukemia. Biochem. Biophys. Res. Commun. 2008; 375; 477-483.
17. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19; 403-410.
18. The Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer 1997; 80; 1798-1802.
19. Divjak M, Glare EM, Walters H. Improvement of non-radio-reactive in situ hybridization in human airway tissues: use of PCR-generated templates for synthesis of probes and an antibody sandwich technique for detection of hybridization. J. Histochem. Cytochem. 2002; 50; 541-548.
20. Watanabe J, Sato Y, Tsuchiya B et al. Qualitative and quantitative assessment of modified in situ reverse transcription-polymerase chain reaction (in situ RT-PCR) method. Acta Histochem. Cytochem. 1999; 32; 423-430.
21. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 1998; 11; 155-168.
22. Iwaya K, Tsuda H, Fujita S et al. Natural state of mutant p53 protein and heat shock protein 70 in breast cancer tissues. Lab. Invest. 1995; 72; 707-714.
23. Zhou W, Zhu M, Wilson MA et al. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J. Mol. Biol. 2006; 356; 1036-1048.
24. Honbou K, Suzuki NN, Horiuchi M et al. The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. J. Biol. Chem. 2003; 278; 31380-31384.
25. Hall CI, Reese ML, Weerapana E et al. Chemical genetic screen identifies Toxoplasma DJ-1 as a regulator of parasite secretion, attachment, and invasion. Proc. Natl Acad. Sci. USA 2011; 108; 10568-10573.
26. Koide-Yoshida S, Niki T, Ueda M et al. DJ-1 degrades transthyretin and inactive form of DJ-1 is secreted in familial amyloidotic polyneuropathy. Int. J. Mol. Med. 2007; 19; 885-893.
27. Allard L, Burkhard PR, Lescuyer P et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin. Chem. 2005; 51; 2043-2205.